Expanded Program On Immunization

Expanded Program on Immunization

Background and Definition

Expanded Program on Immunization (EPI), established in 1987, aimes at guaranteeing the right of every child in Lebanon, regardless of social status or parent's education level, on immunization and protection from diseases that have available effective and safe vaccines. In order to ensure that, the Ministry of Public Health guarantees the provision of vaccines in 700 health care centers, public and social, in collaboration with the private sector and with the conitnuous awareness of care givers about the importance of immunization. The program provides further special attention to chidlren residing in remote and underprivileged areas through quality outreach activities.

EPI ِAims at:

Elevating routine vaccination coverage per district to above 95%.
Preserving Lebanon as polio-free, considering the continuous influx of Syrian refugees and in preparation to the eradication of polio in the region and worldwide.
Eradicating Measles and Rubella by the end of year 2018.

EPI Activities:

Continuous training and capacity building throughout the year for health care workers on routine vaccination management and implementation in all districs.
Continuous work to keep Lebanon certified polio-free
Implementation of the RED STRATEGY to reach every child, which includes:
1. Data on the immunization coverage for children under one year of age
2. Data on immunization coverage in Lebanon
3. Identification of the number of drop-outs and planning to ensure their vaccination per district accordingly
Celebrating World Immunization Week and planning awareness sessions over Lebanon about routine vaccination
Conducting National and Mop-Up Immunization campaigns annually, including vaccination against Measles, Rubella, and Mumps
Conducting regular visits by the self-assessment team to follow on the quality of vaccination delivery service
Continuous collaboration with UNICEFand WHO to follow-up on updates related to immunization worldwide and ensuring implementation in Lebanon considering national and international commitments
Continuous collaboration with the private sector (General Practictioners and Pediatricians) to ensure vaccination for all children in Lebanon, particularly during immunization campaigns and routine immunization.

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
B05CX01	DEXTROSE 7.5% INJECTION USP	G	Glucose - 7.5%	7.50%	Injectable solution	179,456 L.L
B05CX01	DEXTROSE 7.5% INJECTION USP	G	Glucose - 7.5%	7.50%	Injectable solution	163,184 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 33g/100ml	33g/100ml	Injectable solution	287,295 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 33g/100ml	33g/100ml	Injectable solution	312,577 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 50g/100ml	50g/100ml	Injectable solution	329,815 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 20g/100ml	20g/100ml	Injectable solution	807,874 L.L
B05DB	DIANEAL PD4 1.36% GLUCOSE	B	Sodium lactate - 4.48g/l, Magnesium chloride - 0.051g/l, Calcium chloride - 0.184g/l, Sodium chloride - 5.38g/l, Anhydrous glucose - 13.6g/l	1.36%	Injectable solution	1,163,270 L.L
B05DB	DIANEAL PD4 CYCLER 1.36% GLUCOSE	B	Sodium lactate - 4.48g/l, Magnesium chloride - 0.051g/l, Calcium chloride - 0.184g/l, Sodium chloride - 5.38g/l, Anhydrous glucose - 13.6g/l		Injectable solution	1,150,329 L.L
B05DB	DIANEAL PD4 2.27% GLUCOSE	B	Sodium lactate - 4.48g/l, Magnesium chloride - 0.051g/l, Calcium chloride - 0.184g/l, Sodium chloride - 5.38g/l, Anhydrous glucose - 22.7g/l		Injectable solution	1,163,270 L.L
B05DB	DIANEAL PD4 CYCLER 2.27% GLUCOSE	B	Sodium lactate - 4.48g/l, Magnesium chloride - 0.051g/l, Calcium chloride - 0.184g/l, Sodium chloride - 5.38g/l, Anhydrous glucose - 22.7g/l		Injectable solution	1,150,329 L.L
B05DB	DIANEAL PD4 3.86% GLUCOSE	B	Sodium lactate - 4.48g/l, Magnesium chloride - 0.051g/l, Calcium chloride - 0.184g/l, Sodium chloride - 5.38g/l, Anhydrous glucose - 38.6g/l		Injectable solution	1,111,506 L.L
B05DB	DIANEAL PD4 CYCLER 3.86% GLUCOSE	B	Sodium lactate - 4.48g/l, Magnesium chloride - 0.051g/l, Calcium chloride - 0.184g/l, Sodium chloride - 5.38g/l, Anhydrous glucose - 38.6g/l		Injectable solution	1,150,329 L.L
A11CC05	DIBASE	G	Vitamin D3 - 100,000IU/ml	100,000IU/ml	Injectable solution	354,774 L.L
M01AE17	DEXIREN	G	Dexketoprofen - 50mg/2ml	50mg/2ml	Injectable solution	467,657 L.L
D11AH05	DUPIXENT	BioTech	Dupilumab - 300mg	300mg	Injectable solution	123,001,362 L.L
D11AH05	DUPIXENT	BioTech	Dupilumab - 300mg	300mg	Injectable solution	123,001,362 L.L
D11AH05	DUPIXENT	BioTech	Dupilumab - 200mg	200mg	Injectable solution	123,001,362 L.L
D11AH05	DUPIXENT	BioTech	Dupilumab - 200mg	200mg	Injectable solution	123,001,362 L.L
N04BC07	DACEPTON	G	Apomorphine HCl - 30mg/3ml	30mg/3ml	Injectable solution	13,404,432 L.L
N04BC07	DACEPTON	G	Apomorphine HCl Hemihydrate - 100mg/20ml	100mg/20ml	Injectable solution	12,678,532 L.L
L01FC01	DARZALEX	BioTech	Daratumumab - 1800mg	1800mg	Injectable solution	514,508,612 L.L
H02AB02	DEXAMED	G	Dexamethasone - 8mg/2ml	8mg/2ml	Injectable solution	3,547,744 L.L
H02AB02	DEXAMED	G	Dexamethasone - 8mg/2ml	8mg/2ml	Injectable solution	486,471 L.L
H02AB02	DEXAMEDIS FORT	G	Dexamethasone Phosphate - 8mg/2ml	8mg/2ml	Injectable solution	43,003 L.L
H02AB02	DEXAMETHASONE SODIUM PHOSPHATE USP - EIPICO	G	Dexamethasone (sodium phosphate) - 8mg/2ml	8mg/2ml	Injectable solution	185,450 L.L
H02AB02	DEXASINA	G	Dexamethasone Phosphate - 8mg/2ml	8mg/2ml	Injectable solution	3,471,145 L.L
H02AB02	DEXAMETHASON-PANPHARMA	G	Dexamethasone - 5mg/1ml	5mg/1ml	Injectable solution	368,213 L.L
H02AB02	DEXAMETHASONE MEDIS	G	Dexamethasone Phosphate - 4mg/1ml	4mg/1ml	Injectable solution	1,154,361 L.L
B05BB02	DEXTROSE 5% & SODIUM CHLORIDE 0.9%	G	Sodium chloride - 0.9g/100ml, Dextrose, H2O - 5g/100ml		Injectable solution	189,262 L.L
B05BB02	DEXTROSE 5% & SODIUM CHLORIDE 0.9%	G	Sodium chloride - 0.9g/100ml, Dextrose, H2O - 5g/100ml		Injectable solution	182,720 L.L

...